PlainRecalls
FDA Drug Low Class III Terminated

Dofetilide Capsules 500 mcg (0.5mg), 60-count bottle, Rx Only, Manufactured by Sun Pharmaceutical Industries Limited, Survey No. 259/15, Dadra-396 191, (U.T of D & NH), India, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512. NDC 47335-063-86

Reported: August 16, 2023 Initiated: July 18, 2023 #D-1082-2023

Product Description

Dofetilide Capsules 500 mcg (0.5mg), 60-count bottle, Rx Only, Manufactured by Sun Pharmaceutical Industries Limited, Survey No. 259/15, Dadra-396 191, (U.T of D & NH), India, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512. NDC 47335-063-86

Reason for Recall

Out of Specification result observed in content uniformity testing

Details

Units Affected
360 60-count bottles
Distribution
Nationwide in the USA
Location
Princeton, NJ

Frequently Asked Questions

What product was recalled?
Dofetilide Capsules 500 mcg (0.5mg), 60-count bottle, Rx Only, Manufactured by Sun Pharmaceutical Industries Limited, Survey No. 259/15, Dadra-396 191, (U.T of D & NH), India, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512. NDC 47335-063-86. Recalled by SUN PHARMACEUTICAL INDUSTRIES INC. Units affected: 360 60-count bottles.
Why was this product recalled?
Out of Specification result observed in content uniformity testing
Which agency issued this recall?
This recall was issued by the FDA Drug on August 16, 2023. Severity: Low. Recall number: D-1082-2023.